Valesca P Retel

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. doi A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Eur Arch Otorhinolaryngol 273:709-18. 2016
  2. doi Cost-effectiveness of heat and moisture exchangers compared to usual care for pulmonary rehabilitation after total laryngectomy in Poland
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek NKI AVL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Eur Arch Otorhinolaryngol 272:2381-8. 2015
  3. pmc Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study
    Valesca P Retel
    Geneva Cancer Registry, Global Health Institute, University of Geneva, 55 Bd, de la Cluse, Geneva 1205, Switzerland
    BMC Urol 14:86. 2014
  4. doi Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Technol Assess Health Care 25:73-83. 2009
  5. doi Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Breast Cancer Res Treat 131:627-36. 2012
  6. pmc Scenario drafting to anticipate future developments in technology assessment
    Valesca P Retel
    Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    BMC Res Notes 5:442. 2012
  7. pmc A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
    Valesca P Retel
    Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    BMC Cancer 11:475. 2011
  8. doi Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature
    Stella Mook
    Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 17:1406-13. 2010
  9. doi (Very) Early technology assessment and translation of predictive biomarkers in breast cancer
    Anna Miquel-Cases
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands
    Cancer Treat Rev 52:117-127. 2017
  10. doi Value of research and value of development in early assessments of new medical technologies
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Amsterdam, The Netherlands
    Value Health 16:720-8. 2013

Collaborators

Detail Information

Publications18

  1. doi A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Eur Arch Otorhinolaryngol 273:709-18. 2016
    ..To conclude, analysis of presently available data indicates that TB is expected to be cost-effective compared to SLP in a preventive exercise program for concomitant chemo-radiotherapy for advanced head and neck cancer patients...
  2. doi Cost-effectiveness of heat and moisture exchangers compared to usual care for pulmonary rehabilitation after total laryngectomy in Poland
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek NKI AVL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Eur Arch Otorhinolaryngol 272:2381-8. 2015
    ..For the hospital period alone (2 weeks), HMEs were cost-saving: less costly and more effective...
  3. pmc Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study
    Valesca P Retel
    Geneva Cancer Registry, Global Health Institute, University of Geneva, 55 Bd, de la Cluse, Geneva 1205, Switzerland
    BMC Urol 14:86. 2014
    ....
  4. doi Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Technol Assess Health Care 25:73-83. 2009
    ..We used CTA for the introduction of a new diagnostic test in the Netherlands, the 70-gene prognosis signature (MammaPrint) for node-negative breast cancer patients...
  5. doi Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Breast Cancer Res Treat 131:627-36. 2012
    ..With additional data, preferably from head-to-head outcome studies and especially on compliance concerning discordant test results, calculations can be made with higher degrees of certainty...
  6. pmc Scenario drafting to anticipate future developments in technology assessment
    Valesca P Retel
    Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    BMC Res Notes 5:442. 2012
    ..Secondly, we explored the value of this method on the case of the clinical implementation of the 70-gene signature for breast cancer, a gene expression profile for selecting patients who will benefit most from chemotherapy...
  7. pmc A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
    Valesca P Retel
    Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    BMC Cancer 11:475. 2011
    ..This study presents cost-effectiveness analyses of a preventive (swallowing) exercise program (PREP) compared to usual care (UC) from a health care perspective...
  8. doi Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature
    Stella Mook
    Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 17:1406-13. 2010
    ..Therefore, additional prognostic markers are needed to tailor adjuvant systemic treatment for these relatively low-risk patients. The aim of our study was to evaluate the accuracy of the 70-gene MammaPrint signature in T1 breast cancer...
  9. doi (Very) Early technology assessment and translation of predictive biomarkers in breast cancer
    Anna Miquel-Cases
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands
    Cancer Treat Rev 52:117-127. 2017
    ..Closer interaction between clinical researchers and HTA experts throughout the translational research process will ensure that available data and methodologies will be used most efficiently to facilitate biomarker translation...
  10. doi Value of research and value of development in early assessments of new medical technologies
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Amsterdam, The Netherlands
    Value Health 16:720-8. 2013
    ..The "original" signature performed on fresh frozen tissue (70G-FFT) could be further developed to a paraffin-based signature (70G-PAR) to reduce test failures...
  11. doi Review on early technology assessments of nanotechnologies in oncology
    Valesca P Retel
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands
    Mol Oncol 3:394-401. 2009
    ..Assessment methods taking technology dynamics into account, such as Constructive Technology Assessment (CTA) should be considered for evaluation purposes...
  12. doi Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
    Valesca P Retel
    Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Cancer 46:1382-91. 2010
    ....
  13. pmc Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
    Anna Miquel-Cases
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    PLoS ONE 11:e0154386. 2016
    ..In this study, our primary aim is to explore the expected cost-effectiveness of guided-NACT using as a case study the first randomized controlled trial that demonstrated effectiveness (GeparTrio trial)...
  14. doi Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis
    Anna Miquel-Cases
    Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Amsterdam, The Netherlands
    Value Health 19:419-30. 2016
    ..To inform decisions about the design and priority of further studies of emerging predictive biomarkers of high-dose alkylating chemotherapy (HDAC) in triple-negative breast cancer (TNBC) using value-of-information analysis...
  15. doi Incidence of severe tracheobronchitis and pneumonia in laryngectomized patients: a retrospective clinical study and a European-wide survey among head and neck surgeons
    Cindy van den Boer
    Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute Antoni van Leeuwenhoek NKI AVL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Eur Arch Otorhinolaryngol 271:3297-303. 2014
    ..0045, and for the non-HME user group this was 0.0152. There is a tendency that the number of tracheobronchitis and pneumonia episodes in non-HME users is higher than in HME users...
  16. doi Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy
    Anna Miquel-Cases
    Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital NKI AVL, Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands Electronic address
    Breast 24:397-405. 2015
    ..Additionally, we estimated the minimum required prevalence of BRCA1-like and the required positive predictive value (PPV) for a BRCA1-like test to become cost-effective...
  17. ncbi Early phase Technology Assessment of nanotechnology in oncology
    Valesca P Retel
    Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Tumori 94:284-90. 2008
    ..The features of nanotechnology involved are decisive for the selection of CTA aspects, most likely: safety -especially possible interactions with other technologies-, ethics, cost-effectiveness and patient centeredness...